Impact of FilmArray meningitis encephalitis panel on HSV testing and empiric acyclovir use in children beyond the

Kevin Messacar1, James T Gaensbauer1, Meghan Birkholz2

  • 1University of Colorado School of Medicine Aurora, CO USA; Children's Hospital Colorado Aurora, CO USA.

Insights

The FilmArray meningitis and encephalitis panel (MEP) doubled herpes simplex virus (HSV) testing in children with suspected central nervous system infections. While acyclovir initiation remained stable, its duration decreased, highlighting the need for stewardship.

Area of Science:

  • Clinical microbiology
  • Infectious diseases
  • Pediatric neurology

Background:

  • Central nervous system infections in children require rapid and accurate diagnosis.
  • The FilmArray meningitis and encephalitis panel (MEP) offers syndromic testing of cerebrospinal fluid (CSF).
  • Herpes simplex virus (HSV) is a significant cause of encephalitis in pediatric populations.

Purpose of the Study:

  • To evaluate the impact of implementing the FilmArray MEP on HSV testing practices.
  • To assess changes in acyclovir prescribing patterns following MEP implementation.
  • To identify opportunities for diagnostic and antimicrobial stewardship in pediatric CNS infections.

Main Methods:

  • Retrospective analysis of pediatric patients with suspected CNS infections.
  • Comparison of HSV testing rates before and after MEP panel implementation.
  • Analysis of acyclovir initiation and duration of therapy.

Main Results:

  • HSV testing in children over 60 days with suspected CNS infection doubled post-MEP implementation.
  • Acyclovir initiation rates remained unchanged.
  • The duration of acyclovir therapy decreased following MEP implementation.

Conclusions:

  • Rapid syndromic testing with the FilmArray MEP significantly increased HSV diagnostic utilization.
  • While acyclovir initiation was not affected, treatment duration was reduced, suggesting potential for antimicrobial stewardship.
  • Optimizing MEP utilization requires ongoing attention to diagnostic stewardship and appropriate antiviral prescribing.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
141
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
159
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
199